In patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy, one study demonstrated that Akkermansia species was associated with a lower severity of irAEs, while Agathobacter correlated with more severe irAEs, as well as better clinical outcomes (65). The gene discussed is CD274; the disease is lung cancer.